Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis. Their lead candidate is a novel small molecule therapy for acute pancreatitis. This was developed at Mayo Clinic by leading scientists and has profound preclinical efficacy to completely mitigate mortality and morbidity associated with